Anavex Life Sciences Corp (AVXL)
9.11
+0.09
(+1.00%)
USD |
NASDAQ |
Nov 22, 16:00
9.075
-0.04
(-0.38%)
After-Hours: 20:00
Anavex Life Sciences Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2014 | -0.0007M |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | -0.0023M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | -0.0033M |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
Date | Value |
---|---|
September 30, 2009 | |
June 30, 2009 | |
March 31, 2009 | |
December 31, 2008 | |
September 30, 2008 | 0.1046M |
June 30, 2008 | -0.0269M |
March 31, 2008 | -0.0788M |
December 31, 2007 | 0.00 |
September 30, 2007 | 0.00 |
June 30, 2007 | 0.00 |
March 31, 2007 | 0.00 |
December 31, 2006 | 0.00 |
September 30, 2006 | 0.00 |
June 30, 2006 | 0.00 |
March 31, 2006 | 0.00 |
December 31, 2005 | 0.00 |
September 30, 2005 | 0.00 |
June 30, 2005 | 0.00 |
March 31, 2005 | 0.00 |
December 31, 2004 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Microbot Medical Inc | 0.14M |
Alaunos Therapeutics Inc | 0.00 |
SELLAS Life Sciences Group Inc | 0.00 |
Galectin Therapeutics Inc | -- |
Oragenics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -5.18M |
Cash from Financing (Quarterly) | 4.55M |
Free Cash Flow | -30.00M |
Free Cash Flow Per Share (Quarterly) | -0.0613 |
Free Cash Flow Yield | -3.98% |